BIO vs EQBK · rev $651.0M vs P/E 40, rev $215.8M
BIO (BIO) versus Equity Bancshares, Inc. (EQBK) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Equity Bancshares, Inc. (EQBK) is a banks - regional company listed on NYSE.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported EQBK revenue for 2026-06-30 was $215.8M. Net income was $43.4M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. EQBK currently screens at market cap $974.3M and trailing P/E 40.0.
BIO currently screens at market cap $0. EQBK currently screens at market cap $974.3M and trailing P/E 40.0.
Not investment advice. Open the BIO and EQBK stock pages for the full models.
Not investment advice.